Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study
Authors:
- Harry J. LongHLHarry J. Long
- Bradley J. MonkBMBradley J. Monk
- Helen Q. HuangHHHelen Q. Huang
- Edward C. GrendysEGEdward C. Grendys
- D. Scott McMeekinDMD. Scott McMeekin
- Joel SoroskyJSJoel Sorosky
- David S. MillerDavid S. Miller
- Lynne A. EatonLELynne A. Eaton
- James V. FioricaJFJames V. Fiorica
- 1 March 2006
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 100 (3) , 537-543
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2005
- Quality of Life Outcomes From a Randomized Phase III Trial of Cisplatin With or Without Topotecan in Advanced Carcinoma of the Cervix: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2005
- Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2004
- Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapyInternational Journal of Gynecological Cancer, 2003
- Phase II Trial of Topotecan and Cisplatin in Persistent or Recurrent Squamous and Nonsquamous Carcinomas of the CervixGynecologic Oncology, 2002
- A Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervixCancer, 1997
- Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1997
- Phase II Trial of Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced/Recurrent Carcinoma of the Uterine Cervix and VaginaGynecologic Oncology, 1995
- The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.Journal of Clinical Oncology, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958